Zimmer Biomet Holdings, Inc.
ZBH
Classement en actions
#1247
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Prix de l'action
$95.94
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$18.30B
Changement (1 jour)
0.92%
Changement (1 an)
-6.57%
Pays
US
Échange Zimmer Biomet Holdings, Inc. (ZBH)
Catégorie
Healthcare
Bénéfices pour Zimmer Biomet Holdings, Inc. (ZBH)
Bénéfices en Jun 2026 TTM : $933.60M
Selon les derniers rapports financiers de Zimmer Biomet Holdings, Inc., les bénéfices actuels de l'entreprise sont de $933.60M. En 2024, l'entreprise a réalisé un bénéfice de $1.04B, une diminution par rapport à celui de 2023 qui était de $1.07B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Zimmer Biomet Holdings, Inc. de 2000 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $933.60M | 12.37% |
| 2025 | $830.80M | -19.85% |
| 2024 | $1.04B | -2.88% |
| 2023 | $1.07B | 164.51% |
| 2022 | $403.50M | -19.14% |
| 2021 | $499.00M | -574.33% |
| 2020 | $-105.20M | -111.61% |
| 2019 | $905.80M | -434.12% |
| 2018 | $-271.10M | -158.35% |
| 2017 | $464.60M | 16.27% |
| 2016 | $399.60M | 160.84% |
| 2015 | $153.20M | -83.69% |
| 2014 | $939.40M | -4.25% |
| 2013 | $981.10M | -0.91% |
| 2012 | $990.10M | 1.14% |
| 2011 | $978.90M | 13.80% |
| 2010 | $860.20M | -13.82% |
| 2009 | $998.20M | -11.02% |
| 2008 | $1.12B | -0.87% |
| 2007 | $1.13B | -3.20% |
| 2006 | $1.17B | 12.33% |
| 2005 | $1.04B | 42.27% |
| 2004 | $731.50M | 67.20% |
| 2003 | $437.50M | 12.50% |
| 2002 | $388.90M | 61.44% |
| 2001 | $240.90M | -10.11% |
| 2000 | $268.00M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $7.51B | 704.52% |
US
|
|
| $5.56B | 495.87% |
IE
|
|
| $5.15B | 451.41% |
US
|
|
| $3.86B | 313.56% |
US
|
|
| - | - |
DE
|
